AG0037I5

Name: (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
Brand: Angene Chemical
SKU: AG0037I5

23541-50-6 | (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride

Chemical structure of (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride, CAS 23541-50-6

AG0037I5

SDS

COA

TIP This product is typically in stock.Please contact us for quotation.

Request For Quotation

CAS Number	23541-50-6
Catalog Number	AG0037I5(AGN-PC-0QZRNI)
Chemical Name	(8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride
EC Number	245-723-4
IUPAC Name	(7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
InChI	InChI=1S/C27H29NO10.ClH/c1-10-22(30)14(28)7-17(37-10)38-16-9-27(35,11(2)29)8-13-19(16)26(34)21-20(24(13)32)23(31)12-5-4-6-15(36-3)18(12)25(21)33;/h4-6,10,14,16-17,22,30,32,34-35H,7-9,28H2,1-3H3;1H/t10-,14-,16-,17-,22+,27-;/m0./s1
InChI Key	GUGHGUXZJWAIAS-QQYBVWGSSA-N
MDL Number	MFCD04974507
Molecular Formula	C27H30ClNO10
Molecular Weight	563.9808
SMILES	COC1=C2C(C(C(C(O)=C(C[C@](C(C)=O)(O)C[C@@H]4O[C@@]5([H])C[C@H](N)[C@H](O)[C@H](C)O5)C4=C3O)=C3C2=O)=O)=CC=C1.Cl
UN Number	2811
UNII	UD984I04LZ
Synonyms	Cerubidine, Dauno Rubidomycine, Dauno-Rubidomycine, Daunoblastin, Daunoblastine, Daunomycin, Daunorubicin, Daunorubicin Hydrochloride, Hydrochloride, Daunorubicin, NSC 82151, NSC-82151, NSC82151, Rubidomycin, Rubomycin, 23541-50-6, DAUNORUBICIN HCL, DAUNORUBICIN HYDROCHLORIDE, Daunomycin hydrochloride, Daunoblastina, Daunomycin HCL, Rubidomycin hydrochloride, daunorubicinol hydrochloride, Daunoblastin, Rubomycin, Ondena, Daunomycin chlorohydrate, Daunorubicin (Hydrochloride), UNII-UD984I04LZ, CCRIS 915, Daunomycin, hydrochloride, RP 13057 hydrochloride, EINECS 245-723-4, AI3-44887, UD984I04LZ, NDC 0082-4155, (1S,3S)-3-Acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride, MLS000069508, (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride, 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl))oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride, 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trhydroxy-1-methoxy-, hydrochloride, (8S,10S)-, 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-, hydrochloride, FI-6339, MLS001336042, RP-13057, SMR000058559, Daunorubicin HCl (Daunomycin HCl), SR-01000000033, SR-05000001600, Cerubidine (TN), Daunorubicin,(S), (8S,10S)-8-acetyl-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride, (8S,10S)-8-Acetyl-10-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl]oxy]-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride, AK-73029, SMR000768722, MFCD04974507, Daunorubicin hydrochloride [USAN:JAN], Daunorubicin hydrochloride [USAN:USP:JAN], AC1L1XQY, (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride, SCHEMBL4444, CAS-23541-50-6, CHEMBL1563, DSSTox_CID_13382, DSSTox_RID_79068, DSSTox_GSID_33382, MLS002222263, FI 6339 [as the base], daunorubicin-hcl-daunomycin-hcl, FI-6339 [As The Base], RP 13057 [as the base], RP-13057 [as the base], DTXSID0033382, CHEBI:31456, AOB5597, BID0122, GUGHGUXZJWAIAS-QQYBVWGSSA-N, ZX-AFC000806, Daunorubicin hydrochloride(BICINS), EX-A2649, Tox21_201159, CCG-39942, s3035, AKOS015920259, AN-5825, API0002223, CS-1271, Daunorubicin hydrochloride (JP17/USP), KS-5149, NCGC00024246-03, NCGC00258711-01, BR-73029, HY-13062, LS-59205, Q716, AB0069872, AX8041486, Daunorubicin hydrochloride, >=90% (HPLC), ST2419213, FT-0082464, ST51042193, D01264, S-4916, WP900 hydrochloride, >=95% (HPLC), solid, 541D506, SR-01000000033-6, SR-05000001600-3, Daunorubicin hydrochloride, meets USP testing specifications, Daunorubicin Hydrochloride; RP 13057 Hydrochloride; Daunomycin, Daunorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard, Daunorubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard, (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside hydrochloride, (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride, (7S,9S)-9-acetyl-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione hydrochloride, (8S,10S)-8-acetyl-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione hydrochloride, (8S-cis)-8-Acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride, 5,12-Naphthacenedione, 8-acetyl-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)-, Cerubidine, daunorubicin, DaunoXome, daunorubcin hydrochloride, Daunomycin, monohydrochloride, C27H29NO10.ClH, C27H29NO10.HCl, Hydroxydaunorubicin hydrochloride, C27H29NO10, CID62770, C27-H29-N-O10.Cl-H, NSC 82151, ACN-036866, NDC-0082-4155, 23541-50-6 (HCl), B2285, A10194, 20830-81-3, 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S,10S)-, Daunorubicin hydrochloride, 97%, an inhibits both DNA and RNA synthesis - 25MG 25mg, 5,12-Naftacenediona, 8-acetil-10 [(3-amino-2,3,6-trideoxi-alfa-L-lixo-hexopiranosil)] oxi-7,8,9,10-tetrahidro-6,8,11-trihidroxi-1-metoxi-, clorhidrato (1:1), (8S, 10S)-, 5,12-Naphthacenedione, 8-acetyl-10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, hydrochloride, (8S-cis)-,

Complexity	960
Compound Is Canonicalized	Yes
Covalently-Bonded Unit Count	2
Defined Atom Stereocenter Count	6
Defined Bond Stereocenter Count	0
Exact Mass	563.156g/mol
Formal Charge	0
Heavy Atom Count	39
Hydrogen Bond Acceptor Count	11
Hydrogen Bond Donor Count	6
Isotope Atom Count	0
Molecular Weight	563.984g/mol
Monoisotopic Mass	563.156g/mol
Rotatable Bond Count	4
Topological Polar Surface Area	186A^2
Undefined Atom Stereocenter Count	0
Undefined Bond Stereocenter Count	0

GHS Hazard and Precautionary Statements

Symbol:
Hazard Class	6.1
Hazard statements	H301-H334-H351
Packing Group	Ⅲ
Precautionary statements	P261-P281-P301+P310
UN Code	UN 2811

Related Research Chemicals

CERTIFICATE OF ANALYSIS

Chemical Name:	Batch Number:
Chemical Structure:	CAS Registry No:
	Product ID:
	Manufacture Date:
	Storage Temperature:
	Formula:
	Molecular Weight:
	Quantity:

Analysis Data:

Test:

Result:

Conclusion: The above product meets the specifications of Angene.

Analyst:Chase

Date:

Reviewed by:Jessie

Date:

Angene International Limited